Profile for South Korea Patent: 20240060580
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for South Korea Patent: 20240060580
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,799,481 | Dec 16, 2039 | Rvl Pharms | UPNEEQ | oxymetazoline hydrochloride |
| 10,814,001 | Dec 16, 2039 | Rvl Pharms | UPNEEQ | oxymetazoline hydrochloride |
| 10,898,573 | Dec 16, 2039 | Rvl Pharms | UPNEEQ | oxymetazoline hydrochloride |
| 10,940,138 | Dec 16, 2039 | Rvl Pharms | UPNEEQ | oxymetazoline hydrochloride |
| 11,103,482 | Dec 16, 2039 | Rvl Pharms | UPNEEQ | oxymetazoline hydrochloride |
| 11,311,515 | Dec 16, 2039 | Rvl Pharms | UPNEEQ | oxymetazoline hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
